Published studies of the prevalence of the variable number of tandem repeats B/C and human platelet antigen-2a/b polymorphisms in ischemic stroke
. | No. patients . | Controls (%) . | Cases (%) . | OR . | P . |
---|---|---|---|---|---|
VNTR B/C genotype | |||||
Carter et al21 | 605 | 2.0 | 3.0 | — | NS |
Gonzalez-Conejero et al19 | 104 | 8.7 | 21.2 | 2.83 | .011 |
Our study | 219 | 2.1 | 2.4 | — | NS |
HPA-2a/b genotype | |||||
Gonzalez-Conejero et al19 | 104 | 9.8 | 22.5 | 2.4 | <.02 |
Sonado et al22 | 225 | 13.6 | 22.6 | 2.18 | <.0005 |
Carlsson et al20 | 218 | 6.0 | 9.0 | — | NS |
Our study | 219 | 9.0 | 15.0 | 1.8 | .07 |
. | No. patients . | Controls (%) . | Cases (%) . | OR . | P . |
---|---|---|---|---|---|
VNTR B/C genotype | |||||
Carter et al21 | 605 | 2.0 | 3.0 | — | NS |
Gonzalez-Conejero et al19 | 104 | 8.7 | 21.2 | 2.83 | .011 |
Our study | 219 | 2.1 | 2.4 | — | NS |
HPA-2a/b genotype | |||||
Gonzalez-Conejero et al19 | 104 | 9.8 | 22.5 | 2.4 | <.02 |
Sonado et al22 | 225 | 13.6 | 22.6 | 2.18 | <.0005 |
Carlsson et al20 | 218 | 6.0 | 9.0 | — | NS |
Our study | 219 | 9.0 | 15.0 | 1.8 | .07 |
NS indicates not significant. See Tables 1 and 2 for other abbreviations.